References

10.1093/ajhp/zxaa036

10.1093/ajhp/zxaa036 · 2020 · External reference

Unresolved reference

External reference

Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software

10.1345/aph.1p634 · 2011 · External reference

Evaluation for optimal dosing of vancomycin in patients with different physical types

10.1016/j.jiac.2019.04.017 · 2019 · External reference

Investigation of vancomycin AUC deviations in underweight patients

2024 · External reference

Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application

10.1007/s11095-021-03030-y · 2021 · External reference

Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application

10.1016/j.jiac.2024.05.014 · 2024 · External reference

Impacts of age and BMI on vancomycin model choice in a Bayesian software: lessons from a very large multi-site retrospective study

10.1002/phar.4613 · 2024 · External reference

Identification of patients who require two-point blood sampling for the peak and trough values rather than one-point blood sampling for the trough value for the evaluation of AUC of vancomycin using Bayesian estimation

10.1007/s11095-024-03781-4 · 2024 · External reference

Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring

10.1016/j.jiac.2025.102821 · 2025 · External reference

Innovative approaches to optimizing the delivery of vancomycin in individual patients

10.1016/j.addr.2014.05.016 · 2014 · External reference

Non-compartmental analysis

10.1007/978-1-62703-050-2_16 · 2012 · External reference

Comparison of trough-only and peak-trough concentration data for the calculation of vancomycin area under the concentration-time curve on day 1 or day 2

10.1248/bpb.b25-00562 · 2025 · External reference

Unresolved reference

External reference

KDIGO clinical practice guidelines for acute kidney injury

10.1159/000339789 · 2012 · External reference

Prediction of creatinine clearance from serum creatinine

1976 · External reference

Some suggestions for measuring predictive performance

10.1007/bf01060893 · 1981 · External reference

Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients

10.1016/j.cmi.2020.07.005 · 2021 · External reference

Evaluation of vancomycin prediction methods based on estimated creatinine clearance or trough levels

10.1097/ftd.0000000000000250 · 2016 · External reference

Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial

10.1016/j.cardfail.2016.06.423 · 2016 · External reference

Clinical pharmacokinetics of vancomycin

10.2165/00003088-198611040-00001 · 1986 · External reference

Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C

10.2215/cjn.02870707 · 2008 · External reference

Muscle mass and estimates of renal function: a longitudinal cohort study

10.1002/jcsm.12969 · 2022 · External reference

Frequency and characteristics of overestimated renal function in Japanese patients with chronic liver disease and its relation to sarcopenia

10.3390/nu13072415 · 2021 · External reference

Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight

10.1097/00007691-199410000-00013 · 1994 · External reference

Population pharmacokinetics of vancomycin in Japanese adult patients

10.1097/00007691-199804000-00003 · 1998 · External reference